Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | August 20, 2015 |
| Target | Bio-Reference Laboratories |
| Sector | Life Science |
| Buyer(s) | Opko |
| Deal Type | Add-on Acquisition |
| Deal Value | 1.5B USD |
| Advisor(s) | Allen & Company (Financial) Davis Polk & Wardwell (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Life Science |
| Employees | 2,997 |
| Revenue | 713M USD (2024) |
Opko is a diversified healthcare company with a focus on establishing leading positions in significant and rapidly growing medical markets. Opko's operations are divided into diagnostics and pharmaceuticals, each with specialized products and services aimed at improving patient care and outcomes. Opko was founded in 1991 and is based in Miami, Florida.
| Deal Context for Buyer | # |
|---|---|
| Overall | 18 of 20 |
| Sector: Life Science | 7 of 9 |
| Type: Add-on Acquisition | 16 of 18 |
| State: New Jersey | 1 of 1 |
| Country: United States | 6 of 7 |
| Year: 2015 | 2 of 2 |
| Size (of disclosed) | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-05-05 |
EirGen Pharma
Waterford, Ireland EirGen Pharma Ltd. is a specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-30 |
Transition Therapeutics
Toronto, Ontario, Canada Transition Therapeutics Inc. is a bio pharmaceutical company, develops therapeutics for various disease indications. Transition Therapeutics, Inc. was formed in 1987 and is based in Toronto, Ontario. |
Buy | $60M |
